Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells

Abstract Only 40% of patients with advanced ovarian cancer survive more than 5 years. We have previously shown that pitavastatin induces regression of ovarian cancer xenografts in mice. To evaluate whether the response of ovarian cancer cells to pitavastatin is potentiated by farnesyl diphosphate sy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marwan Ibrahim Abdullah, Mohammed Najim Abed, Alan Richardson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8ca55e1241a04e7ca10cbcd71758b463
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!